Cargando…

3D echocardiography, arterial stiffness, and biomarkers in early diagnosis and prediction of CHOP-induced cardiotoxicity in non-Hodgkin’s lymphoma

CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) represents standard chemotherapy in non-Hodgkin's lymphoma (NHL) with risk of cardiotoxicity. To define new parameters, such as 3D myocardial deformation, arterial stiffness, and biomarkers for early diagnosis and prediction of cardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mihalcea, Diana, Florescu, Maria, Bruja, Ramona, Patrascu, Natalia, Vladareanu, Ana-Maria, Vinereanu, Dragos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595195/ https://www.ncbi.nlm.nih.gov/pubmed/33116212 http://dx.doi.org/10.1038/s41598-020-75043-3

Ejemplares similares

Current Insights into the Significance of the Renal Resistive Index in Kidney and Cardiovascular Disease
por: Darabont, Roxana, et al.
Publicado: (2023)

Cardiovascular Toxicity Induced by Vascular Endothelial Growth Factor Inhibitors
por: Mihalcea, Diana, et al.
Publicado: (2023)

Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice
por: Bascuas, Thais, et al.
Publicado: (2018)

Favorable outcome in non-Hodgkin lymphoma of the maxillary sinus treated with R-CHOP
por: Doumas, Stergios, et al.
Publicado: (2013)

CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi
por: Gopal, Satish, et al.
Publicado: (2016)

Echocardiography Monitoring during Anthracycline Administration in Hodgkin and Non-Hodgkin’s Lymphoma: The Tei Index Evaluation
por: Puzzovivo, Agata, et al.
Publicado: (2022)

P045: Plasma proteome profiling of cardiotoxicity in patients with Hodgkin lymphoma
por: Ulfstedt, Johan Mattsson, et al.
Publicado: (2022)

Impaired Cardiac Function in Patients with Multiple Sclerosis by Comparison with Normal Subjects
por: Mincu, Raluca Ileana, et al.
Publicado: (2018)

Methodological Gaps in Left Atrial Function Assessment by 2D Speckle Tracking Echocardiography
por: Rimbaş, Roxana Cristina, et al.
Publicado: (2015)

Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas
por: Fleming, Megan, et al.
Publicado: (2022)

Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin Lymphoma
por: Yang, Jing, et al.
Publicado: (2022)

Multimodality Imaging and Biomarker Approach to Characterize the Pathophysiology of Heart Failure in Left Ventricular Non-Compaction with Preserved Ejection Fraction
por: Visoiu, Ionela-Simona, et al.
Publicado: (2023)

Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy
por: Kim, Tark, et al.
Publicado: (2012)

High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
por: Huang, Li-Wen, et al.
Publicado: (2021)

Lysyl-Oxidase Dependent Extracellular Matrix Stiffness in Hodgkin Lymphomas: Mechanical and Topographical Evidence
por: Alfano, Massimo, et al.
Publicado: (2022)

A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma
por: Swaneveld, F. H., et al.
Publicado: (2007)

High Sensitivity Troponin T as Complementary Modality for Determining Doxorubicin Regimen Cardiotoxicity in Non-Hodgkin Lymphoma Patients
por: Prayogo, Ami Ashariati, et al.
Publicado: (2022)

Cardiotoxicity After Anthracycline Treatment in Survivors of Adult Cancers: Monitoring by USCOM, Echocardiography and Serum Biomarkers
por: Pastore, Alessandro, et al.
Publicado: (2013)

Cancer therapy and cardiotoxicity: The need of serial Doppler echocardiography
por: Galderisi, Maurizio, et al.
Publicado: (2007)

Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report
por: Takeyasu, Yuki, et al.
Publicado: (2017)

Therapy-induced cardiotoxicity in breast cancer patients: a well-known yet unresolved problem
por: Florescu, Diana Ruxandra, et al.
Publicado: (2019)

Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP
por: Dong, Qian, et al.
Publicado: (2022)

Forty years after mediastinal radiotherapy for Hodgkin lymphoma: how late is late cardiotoxicity? A case report
por: Ha, Francis J, et al.
Publicado: (2023)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

R-CHOP versus CHOP in HIV-associated lymphoma: a meta-analysis of prospective studies
por: Echenique, Ignacio, et al.
Publicado: (2012)

The added value of three-dimensional echocardiography in the late diagnosis of a pacemaker complication in a patient with severe congestive heart failure: a case report
por: Mihaila Baldea, Sorina, et al.
Publicado: (2019)

CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study.
por: KÃ¶ppler, H., et al.
Publicado: (1989)

Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP
por: Messori, A, et al.
Publicado: (2001)

Clinical Response to CHOP vs. R-CHOP in Adult Patients with Diffuse Large B-Cell Lymphomas
por: Tariq, Ayesha, et al.
Publicado: (2018)

Plasma Biomarkers for Detecting Hodgkin's Lymphoma in HIV Patients
por: Varnum, Susan M., et al.
Publicado: (2011)

Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy
por: Guo, Wei, et al.
Publicado: (2015)

Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan
por: Yokoyama, Masahiro, et al.
Publicado: (2017)

Prophylaxis for Pneumocystis carinii pneumonia in non-Hodgkin’s lymphoma undergoing R-CHOP21 in China: a meta-analysis and cost-effectiveness analysis
por: Huang, Xiaojia, et al.
Publicado: (2023)

BR vs. R‑miniCHOP in unfit patients with B‑cell non‑Hodgkin lymphoma: A randomized, two‑center, cohort study
por: Zhang, Dongdong, et al.
Publicado: (2023)

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer
por: Visvikis, A, et al.
Publicado: (2020)

The lymphoma microenvironment comes of age in the R-CHOP era?
por: Cooper, Alan, et al.
Publicado: (2023)

Gastric non-Hodgkin’s lymphoma
por: Tzimourtos, Vassilios, et al.
Publicado: (2014)

Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study
por: Nakayama, Takafumi, et al.
Publicado: (2020)

Biomarkers of Uremic Cardiotoxicity
por: Stopic, Bojan, et al.
Publicado: (2021)

A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma
por: Burton, C, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ofvhatm7mktrf24r181hpsi26d